Effect of serotonergic agents on adenosine A2 receptor mediated catalepsy in mice

Psychopharmacology

Volumn 137, Issue 2, 1998, Pages 113-119

  Mandhane, Sanjay N ^a   Khisti, Rahul T ^a   Chopde, Chandrabhan T ^a  

^a RTM NAGPUR UNIVERSITY   (India)

Author keywords

5 HT; 5 HT receptor; Adenosine A2 receptor; Catalepsy; NECA; Serotonin

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 1 METHYL 3 INDAZOLECARBOXYLIC ACID N TROPANYLAMIDE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2 RECEPTOR; FENCLONINE; FENFLURAMINE; FLUOXETINE; KETANSERIN; MIANSERIN; PINDOLOL; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 2A AGONIST; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CATALEPSY; CONTROLLED STUDY; DRUG EFFECT; EXTRAPYRAMIDAL SYMPTOM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC TRANSMISSION;

ANIMALS; ANTIPSYCHOTIC AGENTS; CATALEPSY; FENFLURAMINE; MALE; MICE; RECEPTORS, PURINERGIC P1; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SYNAPTIC TRANSMISSION;

EID: 0031971062     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050600     Document Type: Article

References (44)

1. Arnt J (1982) Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade. Acta Pharmacol Toxicol 51: 321-329
2. Balsara JJ, Jadhav JH, Chandorkar AG (1979) Effects of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy. Psychopharmacology 62: 67-69
3. 2A receptors in the nucleus accumbens mediate locomotor depression. Brain Res Bull 31: 397-404
4. 1C) receptors. J Pharmacol Exp Ther 242: 552-557
5. Curzon G, Gibson EL, Oluyomi AO (1997) Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. Trends Pharmacol Sci 18: 21-25
6. 2 receptor involvement in the hypomobility effects of adenosine analogues in mice. Eur J Pharmacol 168: 285-290
7. 2-mediated behaviour in short-term reserpinized mice. Eur J Pharmacol 192: 30-35
8. 2 receptors induces catalepsy. Neurosci Lett 130: 162-164
9. 2 receptors in rat striatal membranes. Proc Natl Acad Sci USA 88: 7237-7241
10. Ferre S, Fuxe K, von Euler G, Johansson B, Fredholm BB (1992) Adenosine-dopamine interactions in the brain. Neuroscience 51: 501-512
11. 2 dopamine receptors in rat striatum. Mol Brain Res 14: 186-195
12. 3 receptor. J Med Chem 30: 1535-1537
13. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46: 143-156
14. Fuxe K (1965) The distribution of monoamine terminals in the central nervous system. Acta Physiol Scand 64 [Suppl 247]: 41-85
15. Garattini S, Mennini T, Samanin R (1987) From fenfluramine race-mate to d-fenfluramine. Specificity and potency of the effects on the serotonergic system and food intake. Ann NY Acad Sci 499: 156-166
16. 2 receptors. J Med Chem 31: 5-7
17. 2A receptors in the nucleus accumbens and the caudate-putamen. Eur J Pharmacol 323: 127-131
18. Heffner TG, Wiley JN, Williams AE, Bruns RF, Coughenour LL, Downs DA (1989) Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice. Psychopharmacology 98: 31-35
19. Herve D, Pickel VM, Joh TH, Beaudet A (1987) Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res 435: 71-83
20. Jacobson KA, van Galen PJM, Williams M (1992) Adenosine receptors: pharmacology, structure-activity relationships and therapeutic potential. J Med Chem 35: 407-422
21. 2 antagonistic properties. J Pharmacol Exp Ther 244: 685-693
22. 3H] CGS 21680. Eur J Pharmacol 168: 243-246
23. 2 receptor interactions in animal models of schizophrenia. Eur J Pharmacol 295: 147-154.
24. 2 receptor. Life Sci 28: 1015-1022
25. 2 receptor binding sites. Mol Pharmacol 21: 301-314
26. 2 receptors modulate haloperidol-induced catelepsy in rats. Eur J Pharmacol 328: 135-141
27. Martin GE, Rossi DJ, Jarvis MF (1993) Adenosine agonists reduce conditioned avoidance responding in the rat. Pharmacol Biochem Behav 45: 951-958
28. 2 receptors: selective localization in the human basal ganglia and alterations with disease. Neuroscience 42: 697-706
29. 2 adenosine receptor in rat striatal membranes. Drug Dev Res 28: 369-373
30. 2 receptors in unilaterally 6-hydroxydopamine-lesioned rats. Eur J Pharmacol 251: 21-25
31. Neal-Beliveau BS, Joyce JN, Lucki I (1993) Serotonergic involvement in haloperidol-induced catalepsy. J Pharmacol Exp Ther 265: 207-217
32. Nickolson VJ, Wiering JA, Van Delft AML (1982) Comparative pharmacology of mianserin, its main metabolites and 6-azamianserin. Naunyn-Schmiedeberg's Arch Pharmacol 19: 48-55
33. 2A receptors. Trends Pharmacol Sci 17: 364-372
34. Onodera K (1991) Effects of antidepressants and antihistaminics on catalepsy induced by intracerebroventricular administration of histamine in mice. Meth Find Exp Clin Pharmacol 13: 397-403
35. 3H] CGS 21680 as a ligand. Naunyn-Schmiedeberg's Arch Pharmacol 342: 85-89
36. 1C binding sites in rat frontal cortex. J Neurochem 47: 529-540
37. 1 receptors in rat brain. J Pharmacol Exp Ther 216: 142-148
38. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J Neurochem 57: 1062-1067
39. Thielen RJ, Fangon NB, Frazer A (1996) 4-(2′-Methoxyphenyl)-1-[2′-[N′-(2″-pyndinyl)-p- iodobenzamido]ethyl]piperazine and 4-(2′-methoxyphenyl)-1-[2′-[N-(2″-pyridinyl)-p- fluorobenzamido] ethyl]piperazine, two new antagonists at pre-and postsynaptic serotonin-1A receptors. J Pharmacol Exp Ther 277: 661-670
40. 1 receptor and catecholaminergic systems in the behavioral response to 8-hydroxy-2-(di-n-propyl-amino)tetraline in the rat. Eur J Pharmacol 106: 271-282
41. 2 receptors. J Pharmacol Exp Ther 218: 217-230
42. Wadenberg ML (1996) Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat. Neurosci Biobehav Rev 20: 325-339
43. Worms P, Broekkamp CLE, Lloyd K (1983) Behavioural effects of neuroleptic. In: Coyle JT, Enna SJ (eds) Neuroleptics: neurochemical, behavioural and clinical perspectives. Raven Press, New York, pp 93-117
44. Zarrindast MR, Modabber M, Sabetkasai M (1993) Influences of different adenosine receptor subtypes on catalepsy in mice. Psychopharmacology 113: 257-261